Sat Sep 07 11:50:50 UTC 2024: ## Institutional Investors Adjust Holdings in Cencora, Inc. (COR)

**New York, NY -** Belpointe Asset Management LLC reduced its stake in Cencora, Inc. (NYSE:COR) by 11.1% in the second quarter, according to a recent Form 13F filing with the Securities & Exchange Commission. The institutional investor now owns 2,860 shares of the pharmaceutical distributor, valued at $644,000.

This adjustment follows a trend of several other major investors modifying their holdings in Cencora. Consolidated Planning Corp increased its stake by 9.7%, Foundations Investment Advisors LLC grew its position by 2.1%, and FSB Premier Wealth Management Inc. saw a 45.4% increase in its holdings. Fortem Financial Group LLC and Oregon Public Employees Retirement Fund also added to their positions.

Overall, hedge funds and institutional investors own 97.52% of Cencora’s stock. The company’s shares opened at $234.93 on Friday.

Cencora recently announced a quarterly dividend of $0.51 per share, representing an annualized dividend of $2.04 and a dividend yield of 0.87%.

Analysts remain optimistic about Cencora’s performance. Robert W. Baird lowered its price target to $283.00 but maintained an “outperform” rating. Wells Fargo & Company raised its price objective to $249.00 and gave the stock an “equal weight” rating. Other analysts, including JPMorgan Chase & Co. and Leerink Partners, have also expressed positive views on the company.

Cencora’s stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $258.13.

In recent insider trading news, EVP Silvana Battaglia sold 1,473 shares of the company’s stock and major shareholder Walgreens Boots Alliance, Inc. sold 4,438,171 shares.

Cencora, Inc. is a leading distributor of pharmaceutical products, serving various sectors of the healthcare industry. The company’s U.S. Healthcare Solutions segment provides a wide range of products and services, including pharmaceuticals, home healthcare supplies, and pharmacy management consulting.

For further insights on institutional holdings and insider trades, visit HoldingsChannel.com.

Read More